StonvexLoading…
StonvexStonvexStonvexCore line items from AIMD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $161.00 | $124.16K | $113.04K | $110.87K |
Operating Income | $-2.28M | $-13.99M | $-9.69M | $-6.91M |
Net Income | $-2.46M | $-14.77M | $-10.30M | $-7.37M |
EPS (Diluted) | $-0.41 | $-3.46 | $-2.61 | $-2.02 |
Total Assets | $22.08M | $20.87M | $22.68M | $23.92M |
Total Liabilities | $16.39M | $13.31M | $12.63M | $12.48M |
Cash & Equivalents | $2.84M | $417.35K | $1.13M | $1.22M |
Free Cash Flow OCF − CapEx | $-991.96K | $-4.65M | $-3.80M | $-2.60M |
Shares Outstanding | 6.11M | 5.82M | 4.79M | 4.27M |